Harvard Bioscience (HBIO) EBT Margin (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly EBT Margin of 15.93% for Q1 2026, up 21734.0% year-over-year from N/an in Q1 2025, and down 18.03% quarter-over-quarter from 13.5% in Q4 2025.
Harvard Bioscience (HBIO) EBT Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported EBT Margin for 17 consecutive years, with 15.93% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 21734.0% year-over-year to 15.93%; the TTM figure through Mar 2026 stood at 11.57% (up 5186.0% YoY), while the FY2025 annual figure was 66.3%, down 5391.0% from the prior year.
- EBT Margin eased to 15.93% in Q1 2026 per HBIO's latest filing, from 13.5% in the prior quarter.
- Across five years, EBT Margin topped out at 11.71% in Q2 2022 and bottomed at 233.28% in Q1 2025.
- Historically, EBT Margin has averaged 21.91% across 5 years, with a median of 11.02% in 2025.
- Annual changes were most pronounced in 2025 — EBT Margin plunged 21499 bps — and 2026, when it jumped 21734 bps.
- Harvard Bioscience's EBT Margin stood at 3.14% in 2022, then declined by 25 bps to 3.92% in 2023, then soared by 161 bps to 2.4% in 2024, then plunged by 662 bps to 13.5% in 2025, then fell by 18 bps to 15.93% in 2026.
- Business Quant data shows HBIO's EBT Margin at 15.93% in Q1 2026, 13.5% in Q4 2025, and 5.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.71 Bn | 129.49 Bn | 1.96 Bn | 36.46% |
| 2 | Becton Dickinson | 52.48 Bn | 51.62 Bn | 2.32 Bn | 11.12% |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | -1.63% |
| 4 | Resmed | 33.94 Bn | 32.47 Bn | 861.22 Mn | 32.40% |
| 5 | Medline | 29.02 Bn | 26.34 Bn | 2.22 Bn | 3.06% |
| 6 | West Pharmaceutical Services | 25.02 Bn | 24.58 Bn | 329.20 Mn | 20.65% |
| 7 | Solventum | 15.30 Bn | 14.89 Bn | 1.29 Bn | 4.89% |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | -4.48% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 5.34% |
| 10 | Harvard Bioscience | 33.72 Mn | 27.22 Mn | 12.63 Mn | -12.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.74% |
| Mar 31, 2026 | -15.93% |
| Dec 31, 2025 | -13.50% |
| Sep 30, 2025 | -5.51% |
| Jun 30, 2025 | -11.02% |
| Mar 31, 2025 | -233.28% |
| Dec 31, 2024 | 2.40% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -14.20% |
| Mar 31, 2024 | -18.29% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | -2.22% |
| Jun 30, 2023 | -7.30% |
| Mar 31, 2023 | 4.03% |
| Dec 31, 2022 | -3.14% |
| Sep 30, 2022 | -17.42% |
| Jun 30, 2022 | 11.71% |
| Mar 31, 2022 | -24.39% |
| Dec 31, 2021 | 3.42% |
| Sep 30, 2021 | 0.15% |